EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study
Pradermchai Kongkam, Kasenee Tiankanon, Dong Wan Seo, Thanawat Luangsukrerk, Virote Sriuranpong, Chonnipa Nantavithya, Trirat Jantarattana, Arlyn Cañones, Stephen J. Kerr, Kittithat Tantitanawat, Phonthep Angsuwatcharakon, Wiriyaporn Ridtitid, Pinit Kullavanijaya, Rungsun Rerknimitr
Abstract
Abstract Background No study has compared EUS-guided radiofrequency ablation (EUS-RFA) plus systemic chemotherapy (CMT) with CMT alone for unresectable pancreatic ductal adenocarcinoma. Methods This study compared the results of treatment in patients receiving EUS-RFA plus concomitant CMT (group A; n = 14) with those receiving CMT (group B; n = 14) as a pilot study. Results From July 2017 to August 2018, 4 and 2 patients from groups A and B, respectively, withdrew from the study because of progression of the disease. In total, 10 and 12 patients from groups A and B, respectively, completed the study. All 30 EUS-RFA procedures were successful. Mean maximal tumor diameter before treatment of group A ( n = 10) versus B ( n = 12) was 62.2 ± 21.0 versus 50.5 ± 22.0 mm, respectively ( P = not significant). After treatment, no statistically significant difference in mean maximal tumor diameter was found between both groups. However, in group B, mean maximal tumor diameter was significantly increased from 50.5 ± 22.0 to 56.3 ± 18.7 mm, respectively ( P = 0.017). Tumor necrosis occurred in group A versus B at 10 of 10 (100%) versus 6 of 12 (50%) patients, respectively ( P = 0.014). After treatment, group A patients could reduce the mean narcotic pain drug dosage at 26.5 mg of morphine equivalent per day (from 63.6 to 37.1 mg, P = 0.022), whereas group B patients could not reduce the dosage of pain-controlled medication. No statistically significant difference in 6-month mortality rate was found. In group A, 1 procedure-related nonsevere adverse event ( n = 1 of 30 [3.3%]) occurred in 1 patient ( n = 1 of 14 [7.1%]). Conclusions In this study, the mean tumor diameter of group B was significantly increased after the treatment. Group A had a significantly higher rate of necrosis of tumor and required less narcotic.